Preliminary study of two antiviral agents for hepatitis C genotype 1. - Wikidata - awgldk - TriplyDB

Preliminary study of two antiviral agents for hepatitis C genotype 1.

Preliminary study of two antiviral agents for hepatitis C genotype 1.

http://www.wikidata.org/entity/Q34030288

about

Direct-acting antivirals for the treatment of chronic hepatitis C: open issues and future perspectives Treatment for hepatitis C virus-associated cryoglobulinaemic vasculitis Hepatitis C virus protease inhibitor-resistance mutations: our experience and review Recent Advances in Antiviral Therapy for Chronic Hepatitis C Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease KASL clinical practice guidelines: management of hepatitis C The New Era of Interferon-Free Treatment of Chronic Hepatitis C HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy Chronic hepatitis C: future treatment Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus Oral antiviral therapies for chronic hepatitis C infection Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?Antiviral treatment of hepatitis C virus infection and factors affecting efficacy Emerging therapies for the treatment of hepatitis C MiR-122 in hepatitis B virus and hepatitis C virus dual infection Daclatasvir: potential role in hepatitis C Direct acting antivirals for the treatment of chronic viral hepatitis Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline Burden of pediatric hepatitis C Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis Interferon-free combination therapies for the treatment of hepatitis C: current insights Evaluation of persistence of resistant variants with ultra-deep pyrosequencing in chronic hepatitis C patients treated with telaprevir High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus Chimeric mouse model for the infection of hepatitis B and C viruses Deep sequencing analysis of HCV NS3 resistance-associated variants and mutation linkage in liver transplant recipients A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivity Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection Hepatitis C virus infection.NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection.Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C.Advances in the treatment of hepatitis C virus infection Pharmacokinetics of new oral hepatitis C antiviral drugs.Estimating the prevalence of hepatitis C infection in New York City using surveillance data Modelling clinical data shows active tissue concentration of daclatasvir is 10-fold lower than its plasma concentration.Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development.Frontiers in the treatment of hepatitis C virus infection.Hepatitis C virus screening in patients with cancer receiving chemotherapy.

P2860

Q21265028-C16FA6D4-5723-4811-AF93-CB34CA037F26 Q24188154-9F0EF4E1-596A-492A-BD6F-158802BE62D5 Q24628717-7CB98FD1-53B3-410C-8D2D-D555BF369863 Q26750476-1153EFBC-625F-4D5A-B14F-BB23FC7CFC42 Q26752433-565CEB28-E86A-4610-A221-23F3243CD9C7 Q26752471-9298925F-7A10-4B0A-96F1-B0D3AD53CAE3 Q26777716-561402D3-EEDD-4782-B137-268AE5449024 Q26782405-40257B23-2E1F-44C4-8D71-5FA758D9609D Q26824075-078865D3-7C8A-4E2A-B8C7-C70F5B0EA300 Q26830190-1BFA2145-C35D-4517-B89C-24BEDCECF19C Q26830426-0B25662F-0922-408C-9F23-FD5EBFA121D5 Q26830804-609E5E60-24D1-42B4-A2AB-F93F35711935 Q26851810-EC18879A-662D-4904-BFEC-3C9D896C8C98 Q27003319-0C31AA45-BBD9-44E1-87AD-28C2ECC9AF1A Q27008894-2F637954-4137-466B-8FEE-42C560BFE2FC Q27012741-4BFDE275-D632-463A-993B-1129EACCA5DE Q27022216-B9035033-4C6E-4C24-993F-E0E4D1C8FDCC Q27022596-AC49F2DD-1755-4164-91C0-B055F1E34E09 Q27025476-A8D38860-8437-4BB1-ABD0-AF93413FCCC8 Q28070260-8686A0A8-9341-4158-A7CF-382718A100CB Q28077287-1F52CEA2-9431-4580-B30C-908F08176DAD Q28087400-46F4949C-FA9B-4423-83EE-D278F4CDF5E7 Q28481622-D96E8B30-FB87-40EB-9440-058B730C07DF Q28482091-4DCE850E-37B8-4F40-A35A-BC0A86B656B7 Q28534370-86F6BFF4-6D4E-4057-8503-0E719A169D71 Q28534965-0530302D-7F0E-4EFD-864E-3CA7742E78E4 Q28537708-83006172-E1AA-49CF-B989-56C0AFCA9AFD Q28538891-044AB617-016A-4260-BC13-7064814D79DE Q28545971-853CCFCA-98B9-4859-ACCF-4B793E6B594A Q30235491-B7C7466F-6D6B-4D39-95AB-1F5C2CA166A8 Q30352718-4FAAA9E6-BA4E-4A69-8AD4-0D5467E5DE2A Q30402571-58B30633-C5BB-4120-926F-315DDF482FC1 Q30415138-CE19A0D1-BD17-4888-AA63-1D5E7D984F93 Q30422746-F15760E4-56AB-4566-8C59-BBDD5CCDA7B6 Q30622845-EE0902AF-058C-4066-95C5-F76900CA8A3C Q30685690-2A33060D-D44A-41C5-B73C-880D60F5A841 Q31042796-557FFF0F-B6F9-49EA-B176-B781CE90D871 Q31051529-98B87529-B52F-40A1-A609-960D21495CD4 Q33571517-79440602-616B-4845-8A7F-1FEE74485CE3 Q33600085-5993535F-E5FB-455D-B3E7-FE905F1D635F

P2860

Preliminary study of two antiviral agents for hepatitis C genotype 1.

http://www.wikidata.org/entity/Q34030288

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@ast

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@en

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@nl

type

label

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@ast

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@en

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@nl

prefLabel

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@ast

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@en

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@nl

P1433

Q34030288-24DAD8D8-2B91-45C6-93E5-9C5DD25F2E74

P1476

Q34030288-27AE8B24-04CB-46DC-8D18-F447B7F300F0

P2093

Q34030288-005ABAF9-463B-4913-B052-38B2234606A1

Q34030288-35530EC1-91FF-4BDD-A09F-D1EE1E69E6C1

Q34030288-49AB585F-A979-400D-805E-6310DC786630

Q34030288-4B304B36-B471-435D-8563-1F978E27247B

Q34030288-82497ABD-F118-4EEE-891C-BA72F247C070

Q34030288-971019D0-816A-4C34-8B48-B7C5E9DC0A0C

Q34030288-BAE9AC56-05F4-4F36-AF0A-C3E3E461402B

Q34030288-C3ADF9AF-CE64-4FA6-9201-C1FE869C8157

Q34030288-C4CE2DA5-078A-4791-AB35-5D1EAD2764A8

Q34030288-C8810D13-0FA7-4A3E-A570-9C3CDE763A39

P304

Q34030288-3CC215C1-5503-4329-8489-B70749CC3A5D

P31

Q34030288-9136ABB2-252C-48A2-B99D-134E0255783D

P356

Q34030288-5967E4A8-3856-4C80-9302-8272A660DAB8

P407

Q34030288-510AF917-0116-4DB5-ACCC-65AA259A8E19

P433

Q34030288-E3400713-14EA-44E6-9258-AD7727545CA6

P478

Q34030288-8E687597-20F8-4BFB-8134-07347E1A21E5

P50

Q34030288-4055A871-0173-4478-A19B-DCBAB2EAF2CB

P577

Q34030288-90C0E1B3-5D32-44C9-97FD-0E507F9FBF7E

P698

Q34030288-F54523C5-4F2E-4F1A-BFAC-1FF49BA4DB46

P356

P1433

The New England Journal of Medicine

P1476

Preliminary study of two antiviral agents for hepatitis C genotype 1.

@en

P2093

Anna Persson

http://www.w3.org/2001/XMLSchema#string

Anna S Lok

http://www.w3.org/2001/XMLSchema#string

Claudia Martorell

http://www.w3.org/2001/XMLSchema#string

Claudio Pasquinelli

http://www.w3.org/2001/XMLSchema#string

David F Gardiner

http://www.w3.org/2001/XMLSchema#string

Dennis M Grasela

http://www.w3.org/2001/XMLSchema#string

Dessislava I Dimitrova

http://www.w3.org/2001/XMLSchema#string

Eric Lawitz

http://www.w3.org/2001/XMLSchema#string

Fiona McPhee

http://www.w3.org/2001/XMLSchema#string

Gregory T Everson

http://www.w3.org/2001/XMLSchema#string

P304

216-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1104430

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

366

http://www.w3.org/2001/XMLSchema#string

P50

Megan Wind-Rotolo

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22256805

http://www.w3.org/2001/XMLSchema#string